Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

China-backed AIIB approves $250 million loan for Bangladesh's COVID-19 response

Published 05/20/2020, 11:12 PM
Updated 05/20/2020, 11:15 PM
© Reuters. People wait in the queue outside of a coronavirus testing center amid concerns over coronavirus disease (COVID-19) outbreak in Dhaka

BEIJING (Reuters) - Beijing-backed Asian Infrastructure Investment Bank (AIIB) said on Thursday it had approved a $250 million loan to Bangladesh to help the country cope with the coronavirus pandemic.

The project, which will be cofinanced by the Asian Development Bank, is intended to help Bangladesh's government with budget support to help the country's most vulnerable, according to a statement. It is intended to strengthen social safety nets and mitigate the effects of job losses in small and medium sized companies and the informal economy.

"Bangladesh is extremely vulnerable to the COVID-19 virus given that it has one of the highest population densities in the world," said the release.

The loan is part of a $10 billion funding facility the AIIB has announced to help public and private sector entities deal with the pandemic.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.